Devin J. Shaw
Directeur Financier/CFO chez IMMUNE PHARMACEUTICALS, INC.
Postes actifs de Devin J. Shaw
Sociétés | Poste | Début | Fin |
---|---|---|---|
IMMUNE PHARMACEUTICALS, INC. | Directeur Financier/CFO | 13/04/2021 | - |
Historique de carrière de Devin J. Shaw
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Director of Finance/CFO | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Immune Pharmaceuticals, Inc.
Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
- Bourse
- Insiders
- Devin J. Shaw
- Expérience